EyePoint (EYPT) Interest Coverage Ratio (2011 - 2026)
EyePoint (EYPT) reported Interest Coverage Ratio of 2.65 for Q1 2026, up 81.13% on a YoY basis from 1.47 in Q1 2025, and up 95.85% sequentially from 63.95 in Q4 2025.
EyePoint (EYPT) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Interest Coverage Ratio data on file, last reported at 2.65 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 81.13% year-over-year to 2.65; the trailing twelve-month figure through Mar 2026 stood at 8.57 (up 81.55% YoY), and the FY2025 full-year result was 3.33, up 82.94% from the prior year.
- Interest Coverage Ratio climbed to 2.65 in Q1 2026, from 63.95 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 93.08 in Q4 2024 to a low of 63.95 in Q4 2025.
- A 5-year average of 5.86 and a median of 1.37 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 98.06% in 2024 and slumped 2632.11% in 2025, its largest moves.
- Tracing EYPT's Interest Coverage Ratio over 5 years: stood at 56.0 in 2022, then soared by 97.54% to 1.38 in 2023, then soared by 6847.61% to 93.08 in 2024, then tumbled by 168.7% to 63.95 in 2025, then soared by 95.85% to 2.65 in 2026.
- Business Quant data shows EYPT's Interest Coverage Ratio at 2.65 in Q1 2026, 63.95 in Q4 2025, and 1.36 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -2.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.65 |
| Dec 31, 2025 | -63.95 |
| Sep 30, 2025 | -1.36 |
| Jun 30, 2025 | -1.34 |
| Mar 31, 2025 | -14.06 |
| Dec 31, 2024 | 93.08 |
| Sep 30, 2024 | -0.69 |
| Jun 30, 2024 | -0.71 |
| Mar 31, 2024 | -0.51 |
| Sep 30, 2023 | -1.38 |
| Jun 30, 2023 | -1.86 |
| Mar 31, 2023 | -26.54 |
| Dec 31, 2022 | -56.00 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.27 |
| Mar 31, 2022 | -15.31 |
| Dec 31, 2021 | -9.63 |
| Sep 30, 2021 | -11.03 |
| Jun 30, 2021 | -7.98 |
| Mar 31, 2021 | -8.12 |